We know that Chang was NOT "working on CIT at U of Florida, on his own volition."
We know this because a scientist at a University does not use University resources to do ANYTHING "on his or her own volition." That would be unethical and grounds for dismissal and would destroy the Scientist's career.
As for "speculation intensifies over commercial potential of Onko-Sure cancer diagnostic test ...." really? Who is Jason Chew?
Too bad this Jason Chew didn't talk to someone at Radient before writing this "analysis" in January 2011.
"Radient has also begun rolling out a lung cancer screening kit called LC Sentinal in the US with partner, Provista Diagnostics."
No Radient did NOT do this.
"The companies will seek FDA approval for the kit in 2011;"
No they did NOT. No 510(k) or PMA was ever submitted.
"A partner has also been found to further the development of the CIT vaccine technology."
What partner was that? Jaiva? So was the story that Jaiva was going to develop CIT while NuVax was moving on to the U of F technology?
"In December 2010, a new subsidiary, NuVax Therapeutics was formed in collaboration with biotechnology company, Jaiva Technologies to develop the technology as well as additional immunotherapies."
And in December 2010, that new subsidiary, Nuvax Therapeutics, declared that CIT was worthless, and then in January 2011 they licensed Chang's newer work from the U of F. Guess Jason Chew did not interview anyone in January 2011 when he wrote all this.
So who is Jason Chew and what does he say about Radient and CIT today?
Market Data 
Markets 
AI
